NCT06532279: Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
- State
- Under way
- Phase
- Phase 2
- People
- 98 planned
- Started
- 23 Jun 2025
- Primary completion
- 1 Jan 2027
- Arms
- Arm 2 (BMX-001)
- Results
- None posted
- 1 Aug 2024: Trial registered
- 23 Jun 2025: Trial started